PROCEPT BioRobotics Corporation
PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinaā¦ read more
Healthcare
Medical Devices
4 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$29.69
Price-2.40%
-$0.73
1Y
Price
Market Cap
$1.659b
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-29.9%
EBITDA Margin-24.7%
Net Profit Margin-22.5%
Free Cash Flow MarginRevenue
$274.950m
+22.5%
1y CAGR+56.3%
3y CAGR+71.6%
5y CAGREarnings
-$84.145m
+8.0%
1y CAGR+2.8%
3y CAGR-10.4%
5y CAGREPS
-$1.55
+11.4%
1y CAGR+9.1%
3y CAGR-5.1%
5y CAGRBook Value
$385.796m
$513.054m
Assets$127.258m
Liabilities$79.367m
DebtDebt to Assets
15.5%
-1x
Debt to EBITDAFree Cash Flow
-$89.272m
+13.8%
1y CAGR-8.1%
3y CAGR-16.9%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company